PA
MR

Profund Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Profund Advisors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,970
Closed -$840K – 1510
2015
Q4 		$840K Buy
30,970
+1,440
+5% +$37.1K 0.04% 432
2015
Q3 		$646K Sell
29,530
-8,370
-22% -$214K 0.04% 434
2015
Q2 		$1.08M Buy
37,900
+5,860
+18% +$171K 0.04% 376
2015
Q1 		$876K Buy
32,040
+728
+2% +$20K 0.03% 545
2014
Q4 		$827K Sell
31,312
-6,436
-17% -$188K 0.03% 535
2014
Q3 		$1.14M Buy
37,748
+4,372
+13% +$135K 0.05% 341
2014
Q2 		$1.05M Sell
33,376
-1,024
-3% -$32.5K 0.05% 450
2014
Q1 		$1.11M Sell
34,400
-2,972
-8% -$104K 0.05% 406
2013
Q4 		$1.36M Sell
37,372
-2,403
-6% -$93.4K 0.06% 326
2013
Q3 		$1.55M Buy
39,775
+8,029
+25% +$323K 0.08% 225
2013
Q2 		$1.19M Buy
+31,746
New +$1.25M 0.08% 223

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Profund Advisors's MR Position: Q1 2016 in Review

Profund Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 30,970 shares — an estimated $840K sold.

Profund Advisors first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $1.55M in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Profund Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Profund Advisors sold 30,970 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $840K.
  • Profund Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Profund Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.55M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Profund Advisors's 13F filing for Q1 2016, filed 6 May 2016.